Marwan Ghosn

Summary

Country: Lebanon

Publications

  1. doi request reprint A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
    M Ghosn
    Hematology and Medical Oncology Department, Hotel Dieu de France University Hospital, Alfred Naccache BLVD, PO Box 166830 Beirut, Lebanon
    Med Oncol 28:S142-51. 2011
  2. doi request reprint Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Med Oncol 29:2831-7. 2012
  3. ncbi request reprint Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
  4. doi request reprint Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
  5. pmc Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
  6. ncbi request reprint FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
  7. ncbi request reprint Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
  8. ncbi request reprint Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology Oncology Department, Hotel Dieu de France University Hospital, Beirut, Lebanon
    Tunis Med 83:74. 2005
  9. ncbi request reprint Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology Oncology, Hotel Dieu de France Hospital, Beirut, Lebanon
    J Med Liban 50:132-6. 2002
  10. pmc Optimum chemotherapy in the management of metastatic pancreatic cancer
    Marwan Ghosn
    Marwan Ghosn, Hampig Raphael Kourie, Fadi El Karak, Colette Hanna, Joelle Antoun, Dolly Nasr, Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut 166830, Lebanon
    World J Gastroenterol 20:2352-7. 2014

Collaborators

  • Georges Chahine
  • Ayman Tawil
  • Mohamed A Kharfan-Dabaja
  • Fadi Farhart
  • J Kattan
  • N Haddad
  • Zaher K Otrock
  • Ziad Salem
  • Charles Sfeir
  • Michel Saade
  • Walid Dayeh
  • Hussein Sadek
  • Fady Nasr
  • Khaled Ibrahim
  • Saad Khairallah
  • Georges Aftimos
  • Christina Khater
  • Zarouhie Meguerian
  • Claude Ghorra
  • Nizar Bitar
  • Walid Mokaddem
  • Anas Mugharbel
  • Rami A Mahfouz
  • Hassan Sidani
  • Mirna El Hajj
  • Ali Bazarbachi
  • Dany Abi Gerges
  • Gerard Abadjian
  • Jad Saab
  • Fadi S Farhat
  • Ahmad Ibrahim
  • Joseph Makdessi
  • Ghazi Zaatari

Detail Information

Publications11

  1. doi request reprint A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
    M Ghosn
    Hematology and Medical Oncology Department, Hotel Dieu de France University Hospital, Alfred Naccache BLVD, PO Box 166830 Beirut, Lebanon
    Med Oncol 28:S142-51. 2011
    ..2%), and grade 2 alopecia (12%). Conclusion: Both Navcap and Navcap followed by Docetaxel regimens were tolerated with manageable toxicity, offering consistent activities in terms of response rate for metastatic breast cancer patients...
  2. doi request reprint Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Med Oncol 29:2831-7. 2012
    ..In APC, FOLFOX-6 regimen followed by gemcitabine achieved an interesting RR within a tolerable level of toxicity. This regimen seems to warrant further investigation to confirm its efficacy...
  3. ncbi request reprint Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
    ..To evaluate the response rate of the combination of capecitabine (C) and vinorelbine (V) followed by Docetaxel (D) in the 1st line treatment of advanced and metastatic breast cancer patients...
  4. doi request reprint Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
    ..Revisiting the continuum of cancer care is called for to better identify the optimal timing of intervention and avoid end of life distress...
  5. pmc Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
    ..To determine the incidence, characteristics, and survival outcomes of triple-negative breast cancer patients in a medical oncology practice in Lebanon...
  6. ncbi request reprint FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
    ..This phase II trial was conducted to investigate the efficacy of oxaliplatin, 5-FU, and folinic acid (FOLFOX-6) in previously untreated APC patients...
  7. ncbi request reprint Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
    ..The aim of this multicenter phase II trial was to assess the combination of capecitabine and vinorelbine as first-line chemotherapy in patients with metastatic breast cancer (MBC)...
  8. ncbi request reprint Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology Oncology Department, Hotel Dieu de France University Hospital, Beirut, Lebanon
    Tunis Med 83:74. 2005
  9. ncbi request reprint Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology Oncology, Hotel Dieu de France Hospital, Beirut, Lebanon
    J Med Liban 50:132-6. 2002
    ..The duration of stay in the ICU was the only factor affecting mortality. Age, disease type and MV did not influence the mortality rate in this population...
  10. pmc Optimum chemotherapy in the management of metastatic pancreatic cancer
    Marwan Ghosn
    Marwan Ghosn, Hampig Raphael Kourie, Fadi El Karak, Colette Hanna, Joelle Antoun, Dolly Nasr, Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut 166830, Lebanon
    World J Gastroenterol 20:2352-7. 2014
    ....
  11. doi request reprint A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses
    Zaher K Otrock
    Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    Pathol Oncol Res 19:715-22. 2013
    ..The distribution of lymphoma subtypes in Lebanon appears similar to that of Western countries. The high rate of EBV positivity in HL and T-cell lymphoma by EBER deserves further investigation...